[1]
Li, W.; Shi, Z.; Yu, M.; Ren, W.; Smith, C; Epstein, J. H.; Wang, H.; Crameri, G.; Hu, Z.; Zhang, H.; Zhang, J.; McEachern, J.; Field, H.; Daszak, P.; Eaton, B. T.; Zhang, S.; Wang, L.F. Bats are natural reservoirs of SARS-like coronaviruses. Science, 2005, 310, 676-679.
[2]
Revised US. surveillance case definition for severe acute respiratory syndrome (SARS) and update on SARS cases—United States and worldwide, December 2003. Morb. Mortal Wkly Rep., 2003, 52, 1202-1206.
[3]
World Health Organization.; Middle East respiratory syndrome coronavirus (MERS-CoV). Fact sheet. , 2017. Available from:. [https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov).]
[4]
WHO.; Director-General’s opening remarks at the media briefing on COVID-19- 11 March. 2020.Available from:. https://www.who.int/dg/speeches/detail/whodirectorgenerals-opening-remarks-atthe-media-briefing-on-covid-19-11-march-2020.
[5]
An update on coronavirus infected person- (Accessed on May 02, 2020).Available from:. https://www.worldometers.info/coronavirus/
[6]
Dyall, J.; Gross, R.; Kindrachuk, J.; Johnson, R. F.; Olinger Jr., G. G.; Hensley, L. E.; Frieman, M. B.; Jahrling, P. B. Middle east respiratory syndrome and severe acute respiratory syndrome: current therapeutic options and potential targets for novel therapies. Drugs, 2017, 77, 1935-1966.
[7]
Browning, D. J. Toxicology of hydroxychloroquine and chloroquine and the pathology of the retinopathy they cause. In: Hydroxychloroquine and chloroquine retinopathy. Springer: New York, 2014, pp. 65-83.
[8]
Savarino, A.; Lucia, M.B.; Rastrelli, E.; Rutella, S.; Golotta, C.; Morra, E.; Tamburrini, E.; Perno, C.F.; Boelaert, J.R.; Sperber, K.; Cauda, R. Anti- HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors. J. Acquir. Immune. Defic. Syndr., 2004, 35, 223-232.
[9]
Dong, L.; Hu, S.; Gao, J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov. Ther., 2020, 14, 58-60.
[10]
Wang, M.; Cao, R.; Zhang, L.; Yang, X.; Liu, J.; Xu, M.; Shi, Z.; Hu, Z.; Zhong, W.; Xiao, G. Remdesivir and chloroquine effectively inhibit the recently emerged novel corona virus (2019-nCoV) in vitro. Cell Res., 2020, 30, 269-271.
[11]
Li, G.; Clercq, E.D. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat. Rev. Drug Discov., 2020, 19, 149-150.
Current Topics in Medicinal Chemistry
Title:COVID-19: An Update on Clinical Trials
Volume: 20 Issue: 17
Author(s): Yogesh Kumar, Anil Kumar Singh and Shiv Kumar
Affiliation:
Export Options
About this article
Cite this article as:
Kumar Yogesh, Singh Kumar Anil and Kumar Shiv, COVID-19: An Update on Clinical Trials, Current Topics in Medicinal Chemistry 2020; 20 (17) . https://dx.doi.org/10.2174/1568026620999200511092332
DOI https://dx.doi.org/10.2174/1568026620999200511092332 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Article Metrics

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Review on Catastrophic Evolution of SARS-CoV to SARS-CoV2: A Global Pandemic
Coronaviruses A Tour of Unsupervised Deep Learning for Medical Image Analysis
Current Medical Imaging Targeting Natural Products for the Treatment of COVID-19 – An Updated Review
Current Pharmaceutical Design 1+1 > 2: Integration of the Host-directed Traditional Chinese Medicine and the Virus-targeted Modern Medicine in Control of COVID-19
Clinical Cancer Drugs Meet Our Editorial Board Member:
Recent Patents on Anti-Infective Drug Discovery Improved Prediction of Lysine Acetylation by Support Vector Machines
Protein & Peptide Letters Is Ocular Toxicity Expected in Chloroquine/Hydroxychloroquine Prescription as a Therapeutic or Prophylactic Option in COVID-19?
Recent Patents on Anti-Infective Drug Discovery A Pharmacophore Model Specific to Active Site of CYP1A2 with a Novel Molecular Modeling Explorer and CoMFA
Medicinal Chemistry The Role of Chest High Resolution CT and RT-PCR in Diagnosis of Different Stages of Coronavirus (COVID-19) Pneumonia
New Emirates Medical Journal Contrasting Roles of the Galectin-3 in the Schizophrenia Onset, Clinical Presentation, and Somatic Comorbidity
Current Topics in Medicinal Chemistry Pattern and Age Distribution of COVID-19 on Pulmonary Computed Tomography
Current Medical Imaging Current Scenario and Future Prospect in the Management of COVID-19
Current Medicinal Chemistry NPC1 as a Modulator of Disease Severity and Viral Entry of SARSCoV- 2
Current Molecular Medicine Structural Biology Aids the Research of New Anti-COVID-19 Drugs
Current Organic Synthesis Repositioning of Drugs as a Promising Strategy to Fight COVID-19
Coronaviruses <i>In Silico</i> Approach to Predict the SARS-COV2 Derived Candidate MiRNAs as a Potential Antiviral Therapy
Current Drug Therapy The Interplay Among Epilepsy, Parkinson’s Disease and Inflammation: Revisiting the Link through Ca<sup>2+</sup>/cAMP Signalling
Current Neurovascular Research An Overview on COVID-19 and its Effect on Cardiovascular Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Deep Learning in the Quest for Compound Nomination for Fighting COVID-19
Current Medicinal Chemistry COVID 19, All a Radiologist Needs to Know: A Narrative Review
Current Respiratory Medicine Reviews